“In the Bundesliga match between @tsghoffenheim and @1FSVMainz05, players and referees gathered on the pitch before kickoff with a clear message: CURE ME/CFS!Another powerful and successful campaign by http://EmptyStands.me “
If the match is in Germany, why is the sign in English?
When Doctors Couldn’t Solve Their Medical Mysteries, They Turned to A.I.—discusses ME/CFS
https://www.nytimes.com/2026/04/02/well/live/ai-illness-claude-chatgpt.html?unlocked_article_code=1.X1A.mzmz.Rd9qXcpcubDc&smid=nytcore-ios-share
Some women with complex chronic illnesses are using...
Summary
A previously healthy 39-year-old man developed highly symptomatic post-COVID-19 condition (also known as long COVID) marked by cognitive dysfunction, disabling fatigue, and autonomic symptoms unresponsive to multiple multidisciplinary interventions. Given the presence of markedly...
https://www.cdilabs.com/company/leadership
https://www.cancergrandchallenges.org/tyler-hulett
https://finance.yahoo.com/news/cdi-labs-dr-tyler-hulett-113000242.html
He is an autoantibody specialist.
“i’m in a drug study for Baricitinib (REVERSE LC- clinical research trial) and it helps with this! [brain inflammation] it’s been life changing to not have my immune system at its own throat constantly. the study is still open for enrollment i believe!”
Again is this person sure she is not...
Probably more important to do a trial, even smallish, for Abilify/rexulti/vraylar (diff mechanism from fluv.) which should yield a higher positive effect than the effect fluvoxamine demonstrated here.
“Did the daratumumab *just* destroy the myeloma - or did it *also* knock out a T-cell suppressing autoantibody? Daratumumab depletes long-lived plasma cells via CD38 & potentially-harmful immune-altering autoantibodies - not just the cancer! @casanova_lab”
https://www.biospace.com/deals/lilly-wakes-up-sleep-market-with-6-3b-centessa-buy-to-challenge-takeda
This drug delays sleep. Interesting….
“In April 2025, Centessa released Phase 1 datashowing that a 5-mg oral dose of cleminorexton delayed sleep by an average of 37.9 minutes compared to 15.3...
https://finance.yahoo.com/sectors/healthcare/articles/eli-lilly-buy-centessa-pharma-105318456.html
The acquisition gives Lilly ownership of Centessa’s orexin receptor 2 (OX2R) agonist pipeline, including cleminorexton, described as a “potential best-in-class therapeutic” for sleep-wake...
“Did the daratumumab *just* destroy the myeloma - or did it *also* knock out a T-cell suppressing autoantibody? Daratumumab depletes long-lived plasma cells via CD38 & potentially-harmful immune-altering autoantibodies - not just the cancer! @casanova_lab “
Participants were randomly assigned to fluvoxamine (100 mg twice daily).
This is a middle range dose for depression. It would be good if further research could do a dose/response study to see if lower dosages could be effective.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.